Bansisons Tea Industries Ltd — Important, 26-01-2026: Company Update

Novyra Pharmachem Limited's Board of Directors has approved the unaudited financial results for the third quarter and nine months ended December 31, 2025. For the third quarter, the company reported total revenue of 0.02 Cr and a net loss of 0.01 Cr, with basic EPS at (0.02). For the nine-month period, total revenue was 0.06 Cr, resulting in a net loss of 0.02 Cr and basic EPS of (0.03). The Board also reviewed the company's business operations, providing financial transparency to stakeholders.